verapamil has been researched along with aclarubicin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demant, EJ; Friche, E; Hansen, HH; Jensen, PB; Jensen, PS; Sehested, M; Sørensen, BS; Vindeløv, L; Wassermann, K; Westergaard, O | 1 |
Coley, HM; Twentyman, PR; Workman, P | 2 |
Lampidis, TJ; Nguyen-Ba, G; Tapiero, H | 1 |
Dong, J; Johdo, O; Naito, M; Seimiya, H; Tatsuta, T; Tsuruo, T | 1 |
Allan, WP; Creighton, AM; Fattman, CL; Hasinoff, BB; Kuschak, TI; Thampatty, P; Yalowich, JC | 1 |
6 other study(ies) available for verapamil and aclarubicin
Article | Year |
---|---|
Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II.
Topics: Aclarubicin; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Carcinoma, Small Cell; Colony-Forming Units Assay; Daunorubicin; DNA; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Antagonism; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Verapamil | 1991 |
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cyclosporins; Doxorubicin; Drug Combinations; Drug Resistance; Humans; Mice; Tumor Cells, Cultured; Verapamil | 1989 |
Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Topics: Aclarubicin; Animals; Carubicin; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Humans; In Vitro Techniques; Mice; Tumor Cells, Cultured; Verapamil | 1994 |
The efflux of anthracyclines in multidrug-resistant cell lines.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Membrane Glycoproteins; Mice; Phenotype; Tumor Cells, Cultured; Verapamil | 1993 |
Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Nucleus; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblotting; Leukemia P388; Tumor Cells, Cultured; Verapamil; Vincristine | 1995 |
Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.
Topics: Aclarubicin; Animals; CHO Cells; Cricetinae; DNA Topoisomerases, Type II; Drug Resistance; Ethylenediamines; Etoposide; Glycine; Mutation; Razoxane; Thiobarbiturates; Topoisomerase II Inhibitors; Verapamil | 1997 |